Hospital
Boulder City Hospital INC
Boulder City Hospital INC was paid $1.13M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99284, emergency room visit (serious) — 21% of everything it billed.
33Billing provider infoBOULDER CITY HOSPITAL INC
BOULDER CITY, NV 89005
BOULDER CITY, NV 89005
33aNPI1881739613assigned 02/20/2007
33bProvider typeCritical Access Hospital
28Total paid$1.13M
24GClaims86,851
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Nevada
Rank by total paid#3 of 9
Median peer was paid$955K
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,601 | $36K | |
| 2019 | 15,818 | $194K | |
| 2020 | 12,795 | $180K | |
| 2021 | 15,749 | $228K | |
| 2022 | 14,530 | $224K | |
| 2023 | 11,311 | $159K | |
| 2024incomplete | 10,047 | $111K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 2,628 | 2,286 | $236K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 4,161 | 3,692 | $215K |
| A4223 | Infusion supplies not used with external infusion pump, per cassette or bag (list drugs separately) | 15% | 2,794 | 2,188 | $171K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 1,467 | 1,059 | $127K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.3% | 1,448 | 1,333 | $49K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 4.3% | 1,524 | 1,205 | $48K |
| 80053 | Comprehensive metabolic panel | 3.7% | 8,604 | 5,723 | $42K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 3.4% | 1,755 | 624 | $38K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.0% | 1,945 | 1,505 | $23K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.6% | 1,808 | 1,425 | $18K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 9,311 | 6,035 | $17K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.5% | 783 | 660 | $17K |
55 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 1,573 | $16K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 65 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,198 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,246 | $7K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 572 | $6K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,674 | $6K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 167 | $6K |
| G0378 | Hospital observation service, per hour | <1% | 80 | $6K |
| 80061 | Lipid panel | <1% | 893 | $6K |
| 84484 | <1% | 1,856 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 373 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,970 | $5K |
| 83690 | <1% | 1,510 | $4K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,292 | $4K |
| 83735 | <1% | 3,159 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 931 | $3K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 247 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 538 | $3K |
| 83880 | <1% | 393 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,017 | $2K |
| 82607 | <1% | 304 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 193 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 111 | $1K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 69 | $1K |
| 81001 | <1% | 1,535 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 93 | $1K |
| 84436 | <1% | 319 | $989.59 | |
| 80050 | General health panel | <1% | 43 | $923.78 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 154 | $805.44 |
| 85610 | <1% | 891 | $752.64 | |
| 81025 | <1% | 227 | $703.62 | |
| 81003 | <1% | 1,156 | $551.78 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,252 | $472.72 |
| 82746 | <1% | 61 | $451.35 | |
| 82553 | <1% | 149 | $417.64 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 436 | $354.74 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 171 | $259.42 |
| 83605 | <1% | 87 | $223.58 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 132 | $216.16 |
| 86038 | <1% | 41 | $214.50 | |
| 85652 | <1% | 158 | $141.86 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 32 | $95.50 |
| 86140 | <1% | 53 | $84.72 | |
| 81005 | <1% | 88 | $63.64 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 16 | $53.98 |
| 82550 | <1% | 14 | $48.84 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 82 | $43.06 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 12 | $20.25 |
| 84100 | <1% | 13 | $16.15 | |
| 84439 | <1% | 18 | $12.30 | |
| 80320 | <1% | 466 | $11.99 | |
| S1015 | Iv tubing extension set | <1% | 568 | $11.97 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 1,493 | $7.01 |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 0% | 9,414 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBELETE, FREZEWED (CONTROLLER)